Search filters

List of works by Steven G. Self

A Comparison of Testing Parameters and the Implementation of a Group Sequential Design for Equivalence Studies Using Paired-Sample Analysis ⬇️

scientific article published on January 1, 2010

A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens

scientific article

A framework for assessing immunological correlates of protection in vaccine trials

scientific article published on 2 October 2007

China and HIV Vaccine Research: An Old Country with a New Commitment

article

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

scientific article

Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials

scientific article

Endpoints in vaccine trials

scientific article published on 01 April 2004

Equivalence of ELISpot assays demonstrated between major HIV network laboratories

scientific article

Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection

scientific article

Evaluating a surrogate endpoint at three levels, with application to vaccine development

scientific article published on October 2008

Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys

scientific article published on 29 November 2011

Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa

scientific article

HIV fragment gag vaccine induces broader T cell response in mice ⬇️

scientific article published on 01 February 2011

HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1.

scientific article

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

scientific article

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci

scientific article published on 8 February 2017

How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?

scientific article published on November 2005

Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections

scientific article

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia

scientific article

Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study

scientific article (publication date: 2011)

Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America

scientific article published on 01 February 2018

OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial

article by M Rolland et al published 22 October 2009 in Retrovirology

On estimating HLA/disease association with application to a study of aplastic anemia

scientific article published on 01 March 1991

On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trials

scientific article published on 16 June 2006

On testing departure from the binomial and multinomial assumptions

scientific article published in March 1989

On the analysis of viral load endpoints in HIV vaccine trials

scientific article published on 01 July 2003

Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation

scientific article published on 27 June 2006

Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens

scientific article published on 10 February 2016

Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments

scientific article published on August 2009

Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost

article

Proceedings of the Frontiers of Retrovirology Conference 2016.

scientific article published on 26 September 2016

Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys

scientific article published on 24 June 2009

Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'.

scientific article published on February 2009

Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults

scientific article

Statistical approaches to analyzing HIV-1 neutralizing antibody assay data

scientific article

Statistical considerations for the design and analysis of the ELISpot assay in HIV-1 vaccine trials

scientific article published in May 2004

Statistical evaluation of HIV vaccines in early clinical trials.

scientific article

Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

scientific article published on 15 August 2006

The Cox proportional hazards model with change point: an epidemiologic application

scientific article

The use of nonhuman primate models in HIV vaccine development

scientific article

Towards prediction of degenerate CTL epitope recognition

scientific article published on 26 October 2007

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083

scientific article

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials

scientific article published in July 2003

Paulina is supported by:

About Paulina

Help